Board of Directors

The key to direction is leadership.

 

Paul Ellenbogen, M.D., FACR, Chairman of the Board
Paul H. Ellenbogen, M.D., is vice chair of the American College of Radiology® (ACR®) Board of Chancellors. The ACR, with more than 33,000 members, is one of the largest medical specialty organizations in the world. Dr. Ellenbogen is also chair of the ACR Commission on Human Resources and is former chair of the ACR Budget and Finance Committee and ACR Governance Committee. He also serves as Chair of RADPAC and is a member of the editorial board of the Journal of the American College of Radiology (JACR). Dr. Ellenbogen formerly served as president of the Texas Radiological Society and serves on the Expert Physician Panel of the Texas State Board of Medical Examiners. Dr. Ellenbogen is also an Attending Radiologist and past Chair of Radiology at Texas Health Resources Presbyterian Hospital of Dallas. He is a partner in Radiology Associates of North Texas, a private practice with 110 radiologist members, and a Clinical Professor of Radiology at the University of Texas Southwestern Medical School.

 

Jonathan Lewin, M.D., FACR
Jonathan Lewin, M.D., is an internationally prominent scientist who has presented over 100 lectures in 9 different countries on topics in magnetic resonance imaging (MRI). As the Martin Donner Professor and chairman of the Russell H. Morgan department of radiology and radiological science at Johns Hopkins University and the radiologist-in-chief at Johns Hopkins Hospital, Dr. Lewin is known for his interventional and intra-operative MRI. Dr. Lewin also holds leadership positions on several national and international organizations such as the ACR board of chancellors, American Roentgen Ray Society board of directors and the International Society for Strategic Studies in Radiology executive committee.

 

Harvey Neiman, M.D., FACR
Harvey Neiman, M.D., currently serves as CEO of ACR Image Metrix, executive director of ACR, editorial board member of several publications and is a fellow of the American Institute of Ultrasound in Medicine, Society of Radiologists in Ultrasound and the Society of Cardiovascular and Interventional Radiology. Board-certified with additional qualifications, he is a past president of the Society of Radiologists in Ultrasound and the Radiology Advocacy Alliance. Dr. Neiman is a former chief medical officer and chair of the radiology department atWesternPennsylvaniaHospital inPittsburgh,Pennsylvania, chief of cardiovascular radiology atWalterReedArmyMedicalCenter and chief of cardiac radiology atUniversityHospital inAnn Arbor,Michigan.

 

Donald Rosen, M.D.
Donald P. Rosen, M.D., Co-founded RadPharm, Inc. in 1998 and served as its Co-CEO, board member and Chief Strategy Officer until 2008. Dr. Rosen practiced as a diagnostic radiologist in Princeton, NJ, from 1990 until 2011. He currently resides in Southern California with his family and is involved in advisory positions within the clinical trials industry. Prior to that, he was in private practice in Orange County, CA. He has served on the Board of Overseers of Albert Einstein Healthcare Network, the American Cancer Society and the Breast Cancer Resource Center in Princeton. He has lectured at many pharmaceutical and oncology meetings about the uses of diagnostic imaging in oncology clinical trials. Dr. Rosen received his B.A. from the University of Pennsylvania and his M.D. from the University of Cincinnati.

 

Samuel Broder, M.D.
Dr. Broder served as the Vice President and Chief Medical Officer of Celera from 1998 to 2010. He is a physician/scientist with special expertise in the relationship between disorders of the immune system and cancer. His current interests relate to applying knowledge of the human genome, comparative genomics and proteomics to the development of new diagnostics and therapeutics.

 

Dr. Broder began his research career in the Metabolism Branch of the National Cancer Institute (NCI) in 1972. Following the onset of the AIDS epidemic, Dr. Broder’s laboratory was instrumental in developing several of the first drugs now widely used in the therapy of AIDS and its related disorders, including Retrovir® (AZT), Videx®(ddI), and HIVID®(ddC)—the first three antiretroviral agents approved by the FDA. He also oversaw the development of several other agents used to treat cancer, such as TAXOL®. In 1989, President Ronald Reagan named Dr. Broder Director of the National Cancer Institute. Under his leadership, the NCI initiated a number of important large-scale human trials in the prevention, diagnosis and treatment of cancer. Dr. Broder is a member of the Institute of Medicine of the U.S. National Academy of Sciences. He is also the author of more than 300 scholarly papers and holds numerous patents. He received his bachelor’s and M.D. degrees from the University of Michigan. 

 

Carolyn Meltzer, M.D., FACR
Carolyn Meltzer, M.D., William P. Timmie Professor of Radiology in the Emory University School of Medicine and part-time associate dean for research in the School of Medicine, has been named chair of the Department of Radiology. Dr. Meltzer also holds secondary appointments in the Departments of Neurology and Psychiatry & Behavioral Sciences. Dr. Meltzer has served as interim chair of the Radiology Department since August 2006. Dr. Meltzer first joined theSchool ofMedicine in 2005 when she was recruited from theUniversity ofPittsburgh. The primary focus of Dr. Meltzer's research is the evaluation of the brain's structure-function relationships in normal aging, late-life depression and Alzheimer's disease. Her many contributions to academic medicine have arisen in part from her role as a critical bridge between basic investigation and clinical practice. She is also widely known for her lead role in the clinical evaluation of the first combined PET/CT scanner. Dr. Meltzer has been vice chair for research in Radiology at Emory, and her work focuses on research strategy in translational medicine and the Imaging Core Laboratories.

 

Joel Morganroth, M.D. 

Dr. Joel Morganroth, currently EResearch Technology’s (NASDAQ: ERT) Chairman and Chief Scientific Officer, has also been elected as its Interim President and CEO. Dr. Morganroth has served as the Chairman of ERT's Board of Directors since 1999 and as Chief Scientific Officer since April 2006. He previously consulted for ERT since 1977. Dr. Morganroth is also a globally recognized cardiologist and clinical researcher and has had more than 10 years' experience as a medical review officer/expert for the U.S. Food and Drug Administration (FDA).